Filing Details
- Accession Number:
- 0001209191-20-054638
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-10-13 16:34:09
- Reporting Period:
- 2020-10-08
- Accepted Time:
- 2020-10-13 16:34:09
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1757898 | Steris Plc | STE | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1235611 | J Michael Tokich | C/O 70 Sir John Rogerson'S Quay Dublin L2 2 | Sr. Vice Pres., Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Acquisiton | 2020-10-08 | 80 | $53.52 | 45,602 | No | 4 | M | Direct | |
Ordinary Shares | Disposition | 2020-10-08 | 80 | $187.00 | 45,522 | No | 4 | S | Direct | |
Ordinary Shares | Acquisiton | 2020-10-09 | 27,920 | $53.52 | 73,442 | No | 4 | M | Direct | |
Ordinary Shares | Disposition | 2020-10-09 | 6,000 | $187.17 | 67,442 | No | 4 | S | Direct | |
Ordinary Shares | Disposition | 2020-10-09 | 15,677 | $188.24 | 51,765 | No | 4 | S | Direct | |
Ordinary Shares | Disposition | 2020-10-09 | 6,243 | $189.00 | 45,522 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Ordinary Shares | Employee Stock Option (right to buy) | Acquisiton | 2020-10-08 | 80 | $0.00 | 80 | $53.52 |
Ordinary Shares | Employee Stock Option (right to buy) | Acquisiton | 2020-10-09 | 27,920 | $0.00 | 27,920 | $53.52 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
27,920 | 2024-05-30 | No | 4 | M | Direct | |
0 | 2024-05-30 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Ordinary Shares | 3,453 | Indirect | See Footnote Below |
Footnotes
- 15,472 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 6,000 on June 1, 2021; 4,240 on May 31, 2022; 2,780 on May 31, 2023 and 2,452 on June 3, 2024.
- This exercise of stock options and sale of a total of 80 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on June 2, 2020.
- This exercise of stock options and sale of a total of 6,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on June 2, 2020.
- Price reflects a weighted average sale price for multiple transactions ranging from $186.61 to $187.59 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- This exercise of stock options and sale of a total of 15,677 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on June 2, 2020.
- Price reflects a weighted average sale price for multiple transactions ranging from $187.6950 to $188.68 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- This exercise of stock options and sale of a total of 6,243 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on June 2, 2020.
- Price reflects a weighted average sale price for multiple transactions ranging from $188.6950 to $189.2850 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- Units representing 3,453 ordinary share equivalents are held on behalf of the Reporting Person under the STERIS 401(k) Plan as of October, 2020.
- This option to purchase 28,000 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 28,000 Old STERIS ordinary shares for $53.52 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law.